[HTML] mdpi.com

[HTML][HTML] Prevention and management of CMV infections after liver transplantation: current practice in German transplant centers

C Engelmann, M Sterneck, KH Weiss… - Journal of Clinical …, 2020 - mdpi.com
Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human
liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in …
被引用次数：12 相关文章
[PDF] goettingen-research-online.de

[PDF][PDF] Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers

C Engelmann, M Sterneck, KH Weiss, S Templin… - 2020 - publications.goettingen-research …
Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human
liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in …
[PDF] core.ac.uk

[PDF][PDF] Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers

C Engelmann, M Sterneck, KH Weiss, S Templin… - J. Clin. Med, 2020 - core.ac.uk
Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human
liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in …

Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers.

C Engelmann, M Sterneck, KH Weiss… - Journal of Clinical …, 2020 - search.ebscohost.com
Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human
liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in …
[PDF] semanticscholar.org

[PDF][PDF] Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers

C Engelmann, M Sterneck, KH Weiss… - J. Clin …, 2020 - pdfs.semanticscholar.org
Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human
liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in …

Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers.

C Engelmann, M Sterneck, KH Weiss… - Journal of Clinical …, 2020 - europepmc.org
Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human
liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in …

Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers

C Engelmann, M Sterneck, KH Weiss… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human
liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in …

Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers

C Engelmann, M Sterneck… - Journal of Clinical …, 2020 - epub.ub.uni-muenchen.de
Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human
liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in …
[HTML] nih.gov

[HTML][HTML] Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers

C Engelmann, M Sterneck, KH Weiss… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human
liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in …

Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers

C Engelmann, M Sterneck, KH Weiss… - Journal of Clinical …, 2020 - refubium.fu-berlin.de
Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human
liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in …